Alternative Splicing in Human Biology and Disease

Daniel Jutzi*, Marc David Ruepp

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Alternative pre-mRNA splicing allows for the production of multiple mRNAs from an individual gene, which not only expands the protein-coding potential of the genome but also enables complex mechanisms for the post-transcriptional control of gene expression. Regulation of alternative splicing entails a combinatorial interplay between an abundance of trans-acting splicing factors, cis-acting regulatory sequence elements and their concerted effects on the core splicing machinery. Given the extent and biological significance of alternative splicing in humans, it is not surprising that aberrant splicing patterns can cause or contribute to a wide range of diseases. In this introductory chapter, we outline the mechanisms that govern alternative pre-mRNA splicing and its regulation and discuss how dysregulated splicing contributes to human diseases affecting the motor system and the brain.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc
Pages1-19
Number of pages19
DOIs
Publication statusPublished - 2022

Publication series

NameMethods in Molecular Biology
Volume2537
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029

Keywords

  • Alternative splicing
  • Amyotrophic lateral sclerosis
  • Cis-acting regulatory elements
  • Frontotemporal dementia with parkinsonism linked to chromosome 17
  • Myotonic dystrophy type 1
  • snRNPs
  • Spinal muscular atrophy
  • Trans-acting splicing factors

Fingerprint

Dive into the research topics of 'Alternative Splicing in Human Biology and Disease'. Together they form a unique fingerprint.

Cite this